China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a note issued to investors on Monday. The firm set a “hold” rating on the stock.

China Pharma Price Performance

CPHI stock opened at $0.18 on Monday. China Pharma has a 12-month low of $0.13 and a 12-month high of $0.69. The firm has a 50 day moving average of $0.22 and a 200-day moving average of $0.23. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.